/
/
/

Anthem Biosciences Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)850.00
Volume (₹)8.53 L
High (₹)854.80
Upper Circuit1,017.30
Low (₹)824.85
Lower Circuit678.20
Prev Close847.75
52W High (₹)977.55
Price842.10
52W Low (₹)579.15

Share Market Cap & Key Ratios Overview

M.Cap (₹)47790.00 Cr
Div. Yield (%)0.24
PE Ratio82.98
Debt to Equity0.02
Price to Book12.25
Book Value53.57
EPS (TTM)10.22
Face Value2.00
ROE (%)21.98

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
LAURUSLABSNSE
CIPLANSE
DRREDDYNSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
ANTHEMNSE
LTP
1W Low
1W High
Market cap (₹)
1764+4 (0.23%)
1725.50
1778
4,19,620Cr
9030-310 (-3.32%)
8937.50
9431.50
2,39,714Cr
4584.1-72.8 (-1.56%)
4551.80
4682
1,74,741Cr
1140.2+22.7 (2.03%)
1107.30
1150.90
1,12,119Cr
2018.5-18.1 (-0.89%)
2007.80
2069.20
1,10,008Cr
1328+27 (2.08%)
1300.20
1336.40
1,06,061Cr
1218.8+21.8 (1.82%)
1196.90
1250.70
1,01,339Cr
2347.6-20.9 (-0.88%)
2317.50
2426.80
96,244Cr
1677.9-15.1 (-0.89%)
1647.10
1715
95,590Cr
1980.9+24.4 (1.25%)
1925.70
1990.90
89,391Cr
842.1-20.2 (-2.34%)
824.85
889
47,790Cr

Key Highlights of Anthem Biosciences Ltd Balance Sheet

Anthem Biosciences Ltd balance sheet discloses shareholders' funds of ₹112.34Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹112.34Cr, and the reserves and surplus of the company is ₹3039.02Cr.

The company has its non-current liabilities with total liabilities of ₹3707.21Cr as of 2026-03-31.

The current liabilities are ₹489.47Cr as of 2026-03-31. At the same time, current assets are ₹1892.4Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹717.54Cr and tangible assets of ₹612.56Cr, provided in the Anthem Biosciences Ltd financial statements.